Home › NDC Lookup › Labelers › Sanofi Vaccines Us Inc.

Sanofi Vaccines Us Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 49281 (Sanofi Vaccines Us Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

45
Package NDCs
43
Products
36
Active listings
7
Discontinued
25
Ingredients
0
Therapeutic classes
5
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
nirsevimab 6
INFLUENZA A VIRUS A/SWITZERLAND/68... 3
INFLUENZA A VIRUS A/VICTORIA/4897/... 3
SALMONELLA TYPHI TY2 VI POLYSACCHA... 3
Sodium Chloride 2
YELLOW FEVER VIRUS STRAIN 17D-204... 2
CLOSTRIDIUM TETANI TOXOID ANTIGEN... 2
INFLUENZA A VIRUS A/VICTORIA/4897/... 2
corynebacterium diphtheriae toxoid... 2
CLOSTRIDIUM TETANI TOXOID ANTIGEN... 2
By dosage form
INJECTION, SUSPENSION 21
INJECTION 10
INJECTION, SOLUTION 6
KIT 4
INJECTION, POWDER, LYOPHILIZED, FO... 2

Browse records — 43 products

Drug / product Billing NDC NADAC / unit Status
ActHIB HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN KIT Sanofi · NDC 49281-0545-03 · 1 KIT in 1 CARTON (49281-545-03) * .5 mL in 1 VIAL, SINGLE-DOSE (49281-547-58) * .6 mL in 1 VIAL, SINGLE-DOSE (49281-546-58) 49281-0545-03 — On market View →
Adacel TDaP CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN ( 5 [Lf]/.5mL; 2 [Lf]/.5mL; 2.5 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0400-05 · 5 VIAL in 1 PACKAGE (49281-400-05) / .5 mL in 1 VIAL (49281-400-58) 49281-0400-05 — On market View →
Adacel TDaP CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN ( 5 [Lf]/.5mL; 2 [Lf]/.5mL; 2.5 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0400-05 · 5 VIAL in 1 PACKAGE (49281-400-05) / .5 mL in 1 VIAL (49281-400-58) 49281-0400-05 — On market View →
BEYFORTUS nirsevimab 100 mg/mL INJECTION Sanofi · NDC 49281-0574-15 · 5 SYRINGE in 1 CARTON (49281-574-15) / .5 mL in 1 SYRINGE 49281-0574-15 — On market View →
BEYFORTUS nirsevimab 100 mg/mL INJECTION Sanofi · NDC 49281-0575-00 · 1 SYRINGE in 1 CARTON (49281-575-00) / .5 mL in 1 SYRINGE 49281-0575-00 — On market View →
BEYFORTUS nirsevimab 100 mg/mL INJECTION Sanofi · NDC 49281-0574-15 · 5 SYRINGE in 1 CARTON (49281-574-15) / .5 mL in 1 SYRINGE 49281-0574-15 — On market View →
BEYFORTUS nirsevimab 100 mg/mL INJECTION Sanofi · NDC 49281-0575-00 · 1 SYRINGE in 1 CARTON (49281-575-00) / .5 mL in 1 SYRINGE 49281-0575-00 — On market View →
BEYFORTUS nirsevimab 100 mg/mL INJECTION Sanofi · NDC 49281-0575-00 · 1 SYRINGE in 1 CARTON (49281-575-00) / .5 mL in 1 SYRINGE 49281-0575-00 — On market View →
BEYFORTUS nirsevimab 100 mg/mL INJECTION Sanofi · NDC 49281-0574-15 · 5 SYRINGE in 1 CARTON (49281-574-15) / .5 mL in 1 SYRINGE 49281-0574-15 — On market View →
DAPTACEL corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen ( 15 [Lf]/.5mL; 5 [Lf]/.5mL; 10 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0286-01 · 1 VIAL in 1 PACKAGE (49281-286-01) / .5 mL in 1 VIAL (49281-286-58) 49281-0286-01 — On market View →
DAPTACEL corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen ( 15 [Lf]/.5mL; 5 [Lf]/.5mL; 10 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0286-01 · 1 VIAL in 1 PACKAGE (49281-286-01) / .5 mL in 1 VIAL (49281-286-58) 49281-0286-01 — On market View →
Dengvaxia Dengue Tetravalent Vaccine, Live KIT Sanofi · NDC 49281-0605-01 · 1 KIT in 1 CARTON (49281-605-01) * .5 mL in 1 VIAL, SINGLE-DOSE (49281-606-58) * .6 mL in 1 VIAL, SINGLE-DOSE (49281-549-58) 49281-0605-01 — Discontinued View →
Diluent Sodium Chloride 4.5 mg/.5mL INJECTION Sanofi · NDC 49281-0912-05 · 5 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-912-05) / .6 mL in 1 VIAL, SINGLE-DOSE (49281-912-59) 49281-0912-05 — On market View →
Diluent Sodium Chloride 4.5 mg/.5mL INJECTION Sanofi · NDC 49281-0912-05 · 5 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-912-05) / .6 mL in 1 VIAL, SINGLE-DOSE (49281-912-59) 49281-0912-05 — On market View →
FLUBLOK TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN 45 ug/.5mL; 45 ug/.5mL INJECTION Sanofi · NDC 49281-0725-10 · 10 SYRINGE in 1 CARTON (49281-725-10) / .5 mL in 1 SYRINGE (49281-725-88) 49281-0725-10 — Discontinued View →
FLUBLOK TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Missouri/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Darwin/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/Pennsylvania/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN 45 ug/.5mL; 45 ug/.5mL INJECTION Sanofi · NDC 49281-0726-10 · 10 SYRINGE in 1 CARTON (49281-726-10) / .5 mL in 1 SYRINGE (49281-726-88) 49281-0726-10 — On market View →
FLUZONE HD TIV SH 2026 INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACT 60 ug/.5mL; 60 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0016-50 · 10 SYRINGE, GLASS in 1 PACKAGE (49281-016-50) / .5 mL in 1 SYRINGE, GLASS (49281-016-88) 49281-0016-50 — On market View →
FLUZONE HIGH DOSE NORTHERN HEMISPHERE INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug/.5mL; 60 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0125-65 · 5 SYRINGE, GLASS in 1 PACKAGE (49281-125-65) / .5 mL in 1 SYRINGE, GLASS (49281-125-88) 49281-0125-65 — Discontinued View →
FLUZONE HIGH DOSE NORTHERN HEMISPHERE INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE VIRUS) (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TOKYO/EIS1 60 ug/.5mL; 60 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0126-65 · 5 SYRINGE, GLASS in 1 PACKAGE (49281-126-65) / .5 mL in 1 SYRINGE, GLASS (49281-126-88) 49281-0126-65 — On market View →
Fluzone High-Dose Quadrivalent Northern Hemisphere INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 60 ug/.7mL; 60 ug/.7mL INJECTION, SUSPENSION Sanofi · NDC 49281-0226-65 · 10 SYRINGE, GLASS in 1 PACKAGE (49281-226-65) / .7 mL in 1 SYRINGE, GLASS (49281-226-88) 49281-0226-65 — Discontinued View →
Fluzone Quadrivalent Northern Hemisphere INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0926-50 · 10 SYRINGE, GLASS in 1 PACKAGE (49281-926-50) / .5 mL in 1 SYRINGE, GLASS (49281-926-88) 49281-0926-50 — Discontinued View →
Fluzone Quadrivalent Northern Hemisphere INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFL 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0541-15 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-541-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-541-78) 49281-0541-15 — Discontinued View →
FLUZONE TIV SH 2026 INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACT 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0315-15 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-315-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-315-78) 49281-0315-15 — On market View →
FLUZONE TIV SH 2026 INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACT 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0626-50 · 10 SYRINGE, GLASS in 1 PACKAGE (49281-626-50) / .5 mL in 1 SYRINGE, GLASS (49281-626-88) 49281-0626-50 — On market View →
FLUZONE TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0643-15 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-643-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-643-78) 49281-0643-15 — Discontinued View →
FLUZONE TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0425-50 · 10 SYRINGE, GLASS in 1 PACKAGE (49281-425-50) / .5 mL in 1 SYRINGE, GLASS (49281-425-88) 49281-0425-50 — Discontinued View →
FLUZONE TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Switzerland/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACT 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0645-15 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-645-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-645-78) 49281-0645-15 — On market View →
FLUZONE TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Switzerland/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACT 15 ug/.5mg; 15 ug/.5mg INJECTION, SUSPENSION Sanofi · NDC 49281-0426-50 · 10 SYRINGE, GLASS in 1 PACKAGE (49281-426-50) / .5 mg in 1 SYRINGE, GLASS (49281-426-88) 49281-0426-50 — On market View →
IMOVAX RABIES RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER KIT Sanofi · NDC 49281-0252-51 · 90675 · 1 KIT in 1 PACKAGE (49281-252-51) * 1 mL in 1 VIAL, SINGLE-USE (49281-246-58) * 1 mL in 1 SYRINGE (49281-263-58) 49281-0252-51 — On market View →
IPOL POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 40 [D'ag'U]/.5mL; 2 ANTIGEN (FORMALDEHYDE INACTIVATED) 8 [D'ag'U]/.5mL; 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 32 [D'ag'U]/.5mL INJECTION, SUSPENSION Sanofi · NDC 49281-0860-10 · 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-860-10) / 5 mL in 1 VIAL, MULTI-DOSE (49281-860-78) 49281-0860-10 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.